New drugs for the prostate.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000368:Aged; D000726:Androgen Antagonists / Q000627:therapeutic use; D042944:Cholestenone 5 alpha-Reductase / Q000037:antagonists & inhibitors; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives; D006801:Humans; D008297:Male; D008875:Middle Aged; D011470:Prostatic Hyperplasia / Q000188:drug therapy*; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D000317:Adrenergic alpha-Antagonists; D000726:Androgen Antagonists; D004791:Enzyme Inhibitors; D007987:Gonadotropin-Releasing Hormone; D042944:Cholestenone 5 alpha-Reductase